Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes: a Multicenter, Randomized, Prospective, Open-label, Clinical Trial
Phase of Trial: Phase IV
Latest Information Update: 14 Sep 2016
At a glance
- Drugs Sitagliptin (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DIET
- 07 Jun 2017 Biomarkers information updated
- 30 Aug 2016 Status changed from recruiting to completed.
- 27 Apr 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.